Institutional investors purchased a net $5.3 million shares of MRK during the quarter ended December 2013 and now own 75.86% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 11.7 Million shares of Merck & Co Inc
WELLINGTON MANAGEMENT CO. LLP Bought 9.5 Million shares of Merck & Co Inc
JENNISON ASSOCIATES LLC Bought 9.2 Million shares of Merck & Co Inc